2022 Annual Report – 32nd Anniversary
The OUTCOMES RESEARCH Group was formed in 1990 at the University of California in San Francisco and subsequently became an institute when the group’s administrative center moved to the University of Louisville in March of 2000. In 2005, OUTCOMES RESEARCH became a department at the Cleveland Clinic. After 17 years, the Department of OUTCOMES RESEARCH now includes 65 members at the Clinic, among about 200 academic investigators in twenty countries including the Austria, Canada, Ireland, Israel, Japan, China, and the United States. The Consortium is non-profit; its only goal is thus participation in high-quality research.
The Consortium has published more than 1,800 full papers and more than 95 editorials. The collaboration publishes a full paper every other day.
The Consortium is currently involved in about 150 clinical studies, including many large multi-center outcome trials. Funding for the Consortium’s funding is from various peer-reviewed granting agencies, and we also collaborate with companies that make innovative devices and drugs, often conducting major trials that lead to regulatory certification. The Consortium facilitates scientific exchange and collaboration necessary for technically complex outcomes studies involving hundreds or thousands of patients. Additional information is available at www.OR.org.
OUTCOMES RESEARCH seeks to understand the end results of particular health care practices and interventions. End results include effects that people experience and care about, such as change in the ability to function. In particular, for individuals with chronic conditions—where cure is not always possible—end results include quality of life as well as mortality. By linking the care people get to the outcomes they experience, OUTCOMES RESEARCH has become the key to developing better ways to monitor
and improve the quality of care.
The general goal of the OUTCOMES RESEARCH Consortium is to evaluate inexpensive, low-risk interventions that are easy to implement yet likely to markedly improve outcome. For example, we have shown that simply maintaining intraoperative normothermia markedly reduces the risk of complications — and does so at trivial cost. A consequence of our work is that active
intraoperative warming has become routine, whereas it was previously rare. Current focus areas include cardiovascular complications, postoperative delirium, and management of acute surgical pain.
Be the world’s leading clinical anesthesia research organization.
1. Publish more high-impact, peer-reviewed clinical research papers (quantified as number times impact) than any other anesthesia organization.
2. Recruit more extra-mural clinical research funding than any other anesthesia organization, with “clinical research” being defined as research conducted with human subjects.
3. Train clinical investigators at all levels.